Statistics for Health Sciences Acquisitions2 (id:6563 OBIO)

Valuation metrics

Market cap

206.79M

Enterprise value

135.62M

Trailing P/E (ttm)

-3.90

Forward P/E

-3.09

PEG ratio

-3.09

Price/Sales (ttm)

78.12

Price/Book (mrq)

4.47

Enterprise Value/Revenue

51.24

Enterprise Value/EBITDA

-2.27

Overview

Shares outstanding

37.82M

Float

17.58M

Shares short

778.62K

% Held by insiders

0.22%

% Held by institutions

0.55%

Average volume (10 days)

60.97K

Average volume (90 days)

Price summary

52-Week low

4.22

52-Week high

11.69

52-Week change

-20.80%

Beta

0.41

50-Day moving average

5.41

200-Day moving average

6.03

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

93.26%

Operating margin

-1,655.72%

Operational effectiveness

Return on assets

-39.20%

Return on equity

-91.66%

Income statement

Revenue (ttm)

0.07

Revenue per share (ttm)

0.07

Quarterly revenue growth (yoy)

Gross profit (ttm)

2.57M

EBITDA

-59,809,000.00

Net income to common (ttm)

-57,687,000.00

Diluted EPS (ttm)

-1.60

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

66.93M

Total cash per share (mrq)

1.76

Total debt (mrq)

1.84M

Total Debt/Equity (mrq)

3.98

Current ratio (mrq)

422.70%

Book value per share (mrq)

1.22

Cash flow

Cash flow statement

-47,994,000.00

Levered free cash flow (LFCF)

-24,406,624.00